Theuretzbacher U - Search Results

1

Update on antibacterial and antifungal drugs - can we master the resistance crisis?

Theuretzbacher U, Mouton JW. Theuretzbacher U, et al. Curr Opin Pharmacol. 2011 Oct;11(5):429-32. doi: 10.1016/j.coph.2011.08.002. Epub 2011 Sep 6. Curr Opin Pharmacol. 2011. PMID: 21903474 No abstract available.

2

Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes.

Aranzana-Climent V, van Os W, Nutman A, Lellouche J, Dishon-Benattar Y, Rakovitsky N, Daikos GL, Skiada A, Pavleas I, Durante-Mangoni E, Theuretzbacher U, Paul M, Carmeli Y, Friberg LE. Aranzana-Climent V, et al. Among authors: theuretzbacher u. Clin Transl Sci. 2024 Jul;17(7):e13870. doi: 10.1111/cts.13870. Clin Transl Sci. 2024. PMID: 38952168 Free PMC article. Clinical Trial.

3

Evaluating the innovative potential of the global antibacterial pipeline.

Theuretzbacher U. Theuretzbacher U. Clin Microbiol Infect. 2023 Oct 5:S1198-743X(23)00490-1. doi: 10.1016/j.cmi.2023.09.024. Online ahead of print. Clin Microbiol Infect. 2023. PMID: 37805036 Review.

4

Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?

Theuretzbacher U. Theuretzbacher U. Curr Opin Pharmacol. 2007 Oct;7(5):498-504. doi: 10.1016/j.coph.2007.05.003. Epub 2007 Jul 5. Curr Opin Pharmacol. 2007. PMID: 17616438 Review.

5

Tissue concentrations: do we ever learn?

Mouton JW, Theuretzbacher U, Craig WA, Tulkens PM, Derendorf H, Cars O. Mouton JW, et al. Among authors: theuretzbacher u. J Antimicrob Chemother. 2008 Feb;61(2):235-7. doi: 10.1093/jac/dkm476. Epub 2007 Dec 6. J Antimicrob Chemother. 2008. PMID: 18065413 Review.

6

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.

Mouton JW, Ambrose PG, Canton R, Drusano GL, Harbarth S, MacGowan A, Theuretzbacher U, Turnidge J. Mouton JW, et al. Among authors: theuretzbacher u. Drug Resist Updat. 2011 Apr;14(2):107-17. doi: 10.1016/j.drup.2011.02.005. Epub 2011 Mar 26. Drug Resist Updat. 2011. PMID: 21440486 Review.

7

Protein binding: do we ever learn?

Zeitlinger MA, Derendorf H, Mouton JW, Cars O, Craig WA, Andes D, Theuretzbacher U. Zeitlinger MA, et al. Among authors: theuretzbacher u. Antimicrob Agents Chemother. 2011 Jul;55(7):3067-74. doi: 10.1128/AAC.01433-10. Epub 2011 May 2. Antimicrob Agents Chemother. 2011. PMID: 21537013 Free PMC article. Review.

8

Resistance drives antibacterial drug development.

Theuretzbacher U. Theuretzbacher U. Curr Opin Pharmacol. 2011 Oct;11(5):433-8. doi: 10.1016/j.coph.2011.07.008. Epub 2011 Aug 19. Curr Opin Pharmacol. 2011. PMID: 21862408 Review.

9

Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.

Pulcini C, Bush K, Craig WA, Frimodt-Møller N, Grayson ML, Mouton JW, Turnidge J, Harbarth S, Gyssens IC; ESCMID Study Group for Antibiotic Policies. Pulcini C, et al. Clin Infect Dis. 2012 Jan 15;54(2):268-74. doi: 10.1093/cid/cir838. Clin Infect Dis. 2012. PMID: 22198992 Review.

10

Consistent global approach on reporting of colistin doses to promote safe and effective use.

Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD. Nation RL, et al. Among authors: theuretzbacher u. Clin Infect Dis. 2014 Jan;58(1):139-41. doi: 10.1093/cid/cit680. Epub 2013 Oct 8. Clin Infect Dis. 2014. PMID: 24107410 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters